These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 22436203)
1. The CAMCOG for patients with Alzheimer's disease with low levels of education. Lourenço RA; Paradela EM Int Psychogeriatr; 2012 Aug; 24(8):1359-60; author reply 1360-1. PubMed ID: 22436203 [No Abstract] [Full Text] [Related]
2. Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education? Aprahamian I; Martinelli JE; Cecato J; Izbicki R; Yassuda MS Int Psychogeriatr; 2011 Feb; 23(1):96-101. PubMed ID: 20678300 [TBL] [Abstract][Full Text] [Related]
3. Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors. Gallagher D; Mhaolain AN; Coen R; Walsh C; Kilroy D; Belinski K; Bruce I; Coakley D; Walsh JB; Cunningham C; Lawlor BA Int J Geriatr Psychiatry; 2010 Dec; 25(12):1280-7. PubMed ID: 21086538 [TBL] [Abstract][Full Text] [Related]
4. The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds. Aprahamian I; Martinelli JE; Neri AL; Yassuda MS Int Psychogeriatr; 2010 Feb; 22(1):64-71. PubMed ID: 19814841 [TBL] [Abstract][Full Text] [Related]
5. Epidemiological dementia index: a screening instrument for Alzheimer's disease and other types of dementia suitable for use in populations with low education level. Fountoulakis KN; Tsolaki M; Mohs RC; Kazis A Dement Geriatr Cogn Disord; 1998; 9(6):329-38. PubMed ID: 9769446 [TBL] [Abstract][Full Text] [Related]
6. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up. Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151 [TBL] [Abstract][Full Text] [Related]
7. Clock drawing test in mild and moderate dementia of the Alzheimer's type: a comparative and correlation study. Heinik J; Solomesh I; Shein V; Becker D Int J Geriatr Psychiatry; 2002 May; 17(5):480-5. PubMed ID: 11994938 [TBL] [Abstract][Full Text] [Related]
8. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Ballard CG; Ayre G; O'Brien J; Sahgal A; McKeith IG; Ince PG; Perry RH Dement Geriatr Cogn Disord; 1999; 10(2):104-8. PubMed ID: 10026383 [TBL] [Abstract][Full Text] [Related]
9. [Neuropsychological diagnosis and therapeutic management of a patient with suspicion of Alzheimer's disease]. Calicis F; Jacquemin A; Van der Linden M; Wyns C Acta Neurol Belg; 1989; 89(3-4):311-2. PubMed ID: 2516984 [No Abstract] [Full Text] [Related]
10. Can clock drawing test help to differentiate between dementia of the Alzheimer's type and vascular dementia? A preliminary study. Heinik J; Solomesh I; Raikher B; Lin R Int J Geriatr Psychiatry; 2002 Aug; 17(8):699-703. PubMed ID: 12211117 [TBL] [Abstract][Full Text] [Related]
11. [Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests]. Lanfranco RG; Manríquez-Navarro P; Avello LG; Canales-Johnson A Rev Med Chil; 2012 Sep; 140(9):1191-200. PubMed ID: 23354643 [TBL] [Abstract][Full Text] [Related]
12. [Neuropsychological exploration in dementia: presentation of a neuropsychologic battery in the study of Alzheimer's disease]. Gil i Saladié D; Jarne i Esparcia A; Delgado i González M; Peña i Casanova J Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(1):47-53. PubMed ID: 2330849 [TBL] [Abstract][Full Text] [Related]
13. Neuropathological and neuropsychological changes in Alzheimer's disease. Relationship of biologic markers to behavioral markers. Pirozzolo FJ; Inbody SB; Sims PA; Strittmatter WJ; Baskin D Clin Geriatr Med; 1989 Aug; 5(3):425-40. PubMed ID: 2680026 [TBL] [Abstract][Full Text] [Related]
14. [Clinical presentation of Moroccan cases with Alzheimer's disease]. El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896 [TBL] [Abstract][Full Text] [Related]
15. [Contribution of the set-test to the diagnosis of Alzheimer's disease]. Pascual Millán LF; Martínez Quiñones JV; Modrego Pardo P; López del Val LJ; Mostacero Miguel E; Morales Asín F Neurologia; 1991 Mar; 6(3):78-83. PubMed ID: 2054205 [TBL] [Abstract][Full Text] [Related]
16. Does Mount Vesuvius indicate an outbreak of Alzheimer's disease? Toepper M; Boedeker S; Bauer E; Westphal S; Driessen M; Beblo T J Am Geriatr Soc; 2014 Oct; 62(10):1989-91. PubMed ID: 25333539 [No Abstract] [Full Text] [Related]
17. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH; Schmand BA Pharmacoepidemiol Drug Saf; 2007 May; 16(5):545-51. PubMed ID: 17109476 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease and depression: neuropsychological impairment and progression of the illness. Lopez OL; Boller F; Becker JT; Miller M; Reynolds CF Am J Psychiatry; 1990 Jul; 147(7):855-60. PubMed ID: 2356870 [TBL] [Abstract][Full Text] [Related]
20. [On "Proposal for the application and scoring of the clock drawing test in Alzheimer's disease"]. Royall DR; Román GC Rev Neurol; 1999 Dec 16-31; 29(12):1348-9. PubMed ID: 10652771 [No Abstract] [Full Text] [Related] [Next] [New Search]